Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change $ Change
grade A $123.47 0.98% 1.2
ABMD closed up 0.98 percent on Wednesday, March 22, 2017, on 57 percent of normal volume.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ABMD trend table...

Date Alert Name Type % Chg
Mar 22 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 22 Slingshot Bullish Bullish Swing Setup 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 180 Bullish Setup Bullish Swing Setup 0.00%
Mar 20 Slingshot Bullish Bullish Swing Setup -0.10%
Mar 16 Cup with Handle Other 0.46%
Mar 16 Jack-in-the-Box Bullish Bullish Swing Setup 0.46%
Mar 15 Expansion Breakout Bullish Swing Setup 0.41%
Mar 15 180 Bullish Setup Bullish Swing Setup 0.41%
Mar 14 Bearish Engulfing Bearish 2.44%

Older signals for ABMD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Is ABMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 132.95
52 Week Low 89.74
Average Volume 405,801
200-Day Moving Average 115.6653
50-Day Moving Average 114.7464
20-Day Moving Average 120.737
10-Day Moving Average 122.278
Average True Range 2.2468
ADX 31.93
+DI 25.66
-DI: 10.55
Chandelier Exit (Long, 3 ATRs) 118.0896
Chandelier Exit (Short, 3 ATRs) 121.0204
Upper Bollinger Band 124.8692
Lower Bollinger Band 116.6048
Percent B (%b) 0.83
Bandwidth 0.06845